Global Point of Care Infectious Disease Testing Market
As the global economy mends, the 2021 growth of Point of Care Infectious Disease Testing will hav ... Read More
As the global economy mends, the 2021 growth of Molecular Diagnostics Devices and Equipment will have significant change from previous year. According to our (LP Information) latest study, the global Molecular Diagnostics Devices and Equipment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Molecular Diagnostics Devices and Equipment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Molecular Diagnostics Devices and Equipment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Molecular Diagnostics Devices and Equipment market, reaching US$ million by the year 2028. As for the Europe Molecular Diagnostics Devices and Equipment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Molecular Diagnostics Devices and Equipment players cover Roche, Hologic, QIAGEN, and Abbott, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostics Devices and Equipment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Instruments
Reagents
Consumables
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Diagnostic Laboratories
Hospitals
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Hologic
QIAGEN
Abbott
Danaher Corporation
BD
Siemens Healthcare
Bio-Rad
As the global economy mends, the 2021 growth of Point of Care Infectious Disease Testing will hav ... Read More
As the global economy mends, the 2021 growth of Metastatic Melanoma Diagnostic will have signific ... Read More
As the global economy mends, the 2021 growth of Melanoma Skin Cancer Diagnostic Testing will have ... Read More
As the global economy mends, the 2021 growth of Aircraft Pneumatic Seat Actuation System will hav ... Read More